CoChat

Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage

Algire, Carolyn, Moiseeva, Olga, Deschênes-Simard, Xavier, Amrein, Lilian, Petruccelli, Luca, Birman, Elena, Viollet, Benoit, Ferbeyre, Gerardo, Pollak, Michael N. · 2012 · Cancer Prevention Research

Published version of a preprint

The DOI matches its Crossref record; 40 of the 40 references it cites were found in a registry or an index.

Abstract

Pharmacoepidemiologic studies provide evidence that use of metformin, a drug commonly prescribed for type II diabetes, is associated with a substantial reduction in cancer risk. Experimental models show that metformin inhibits the growth of certain neoplasms by cell autonomous mechanisms such as activation of AMP kinase with secondary inhibition of protein synthesis or by an indirect mechanism involving reduction in gluconeogenesis leading to a decline in insulin levels and reduced proliferation of insulin-responsive cancers. Here, we show that metformin attenuates paraquat-induced elevations in reactive oxygen species (ROS), and related DNA damage and mutations, but has no effect on similar changes induced by H(2)0(2), indicating a reduction in endogenous ROS production. Importantly, metformin also inhibited Ras-induced ROS production and DNA damage. Our results reveal previously unrecognized inhibitory effects of metformin on ROS production and somatic cell mutation, providing a novel mechanism for the reduction in cancer risk reported to be associated with exposure to this drug.

Overview

Integrity signals

Registry

Crossref · 10.1158/1940-6207.capr-11-0536

Cites

40 of 40 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 40 references

Cited by

See all 376

Metadata

Authors
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N.
Affiliations
  • Inserm (FR)
  • Authors' Affiliations: 1Division of Experimental Medicine, McGill University and Segal Cancer Centre of Jewish General Hospital; 2Département de Biochimie, Université de Montréal, Montréal, Québec, Canada; 3INSERM, U1016, Institut Cochin, Paris France; 4CNRS UMR8104, Paris, France; and 5Université Paris Descartes, Sorbonne Paris Cité, Paris France
Venue
Cancer Prevention Research
Published
2012-04-01
Volume
5
Issue
4
Pages
536-543
ISSN
  • 1940-6207 (ISSN-L)
  • 1940-6215
OpenAlex
W2140204893
Cited by
372
References
40
Citations by year
2026: 10 · 2025: 19 · 2024: 21 · 2023: 42 · 2022: 31 · 2021: 34 · 2020: 41 · 2019: 25 · 2018: 22 · 2017: 29 · 2016: 22 · 2015: 15 · 2014: 25 · 2013: 19 · 2012: 17
FWCI
9.76
Type
journal article
Language
en
Open access
closed
Locations
  • Cancer Prevention Research (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Paraquat toxicity studies and treatments
  • Life Sciences › Pharmacology, Toxicology and Pharmaceutics › Toxicology › Bioactive Compounds and Antitumor Agents
Keywords
metformin, reactive oxygen species, DNA damage, somatic mutations, paraquat, hydrogen peroxide, Ras, chemoprevention, type 2 diabetes, AMP kinase, insulin
MeSH terms
Adenylate Kinase, Animals, Cell Line, Diabetes Mellitus, Type 2, DNA Damage, Enzyme-Linked Immunosorbent Assay, Epidermal Growth Factor, Fibroblasts, Flow Cytometry, Humans, Hydrogen Peroxide, Hypoglycemic Agents, Insulin, Male, Metformin, Mice, Inbred C57BL, Microscopy, Fluorescence, Mutation, NADP, Mutagenesis, Reactive Oxygen Species, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. https://app.cochat.ai/papers/10.1158/1940-6207.capr-11-0536
The paper
Algire, C., Moiseeva, O., Deschênes-Simard, X., Amrein, L., Petruccelli, L., Birman, E., Viollet, B., Ferbeyre, G., & Pollak, M. N. (2012). Metformin Reduces Endogenous Reactive Oxygen Species and Associated DNA Damage. Cancer Prevention Research. https://doi.org/10.1158/1940-6207.capr-11-0536

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.